Patents Assigned to Ranbaxy Laboratories Limited
  • Pyrazolo (3, 4-B) pyridine derivatives as phosphodiesterase inhibitors
    Patent number: 8420666
    Abstract: The present invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7 and dual PDE type 4/PDE type 7 inhibitors.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: April 16, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Sonali Rudra, Nidhi Gupta, Lalit Kumar Baregama, Ritu Agarwal, Vinayak Vasantrao Khairnar, Mandadapu Raghu Ramaiah, Venkata P. Palle, Sarala Balachandran, Atul Kondaskar, Manohar Salla, Abhijit Ray, Sunanda G. Dastidar, Lalitha Vijaykrishnan
  • Barium salt of benzimidazole derivative
    Patent number: 8415478
    Abstract: The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared.
    Type: Grant
    Filed: February 9, 2010
    Date of Patent: April 9, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Yatendra Kumar, Mahavir Singh Khanna, Mohan Prasad
  • PROCESSES FOR PREPARATION OF POLYMORPHIC FORMS OF LACOSAMIDE
    Publication number: 20130085304
    Abstract: The present invention relates to processes for the preparation of crystalline polymorphic forms of lacosamide (Formula I), including processes for inter-conversion among such polymorphic forms.
    Type: Application
    Filed: November 19, 2010
    Publication date: April 4, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Mukesh Kumar Madhra, Hari Mohan Sriram, Mukesh Kumar Sharma, Satish Chandra Jha
  • PROCESS FOR THE PREPARATION OF BORTEZOMIB
    Publication number: 20130085277
    Abstract: The present invention relates to a process for the preparation of bortezomib (Formula I) and its intermediates.
    Type: Application
    Filed: February 9, 2011
    Publication date: April 4, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Satish Kumar, Venugopal Venkatarama Durvasula, Parendu Dhirajlal Rathod, Ram Chander Aryan
  • Barium salt of benzimidazole derivative
    Patent number: 8404854
    Abstract: The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared.
    Type: Grant
    Filed: February 9, 2010
    Date of Patent: March 26, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Yatendra Kumar, Mahavir Singh Khanna, Mohan Prasad
  • PROCESS FOR STEREOSELECTIVE SYNTHESIS OF 5-FLUORO-1-(2R,5S)-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE
    Publication number: 20130072681
    Abstract: The present invention provides an improved process for stereoselective preparation of 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: February 25, 2011
    Publication date: March 21, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Prakash Bhimaji Kshirsagar, Satish Manohar Bhoge, Santosh Richhariya, Kaptan Singh
  • Intermediate compounds and their use in preparation of lacosamide
    Patent number: 8378142
    Abstract: The present invention is concerned with novel compounds and their use for the preparation of lacosamide. The present invention also contemplates processes for the preparation of lacosamide employing the novel compound of general Formula II, Formula IIa or Formula IIb as intermediate. Wherein R1 is —OH or —OMe; R2 is —OH or —NH—CH2—C6H5.
    Type: Grant
    Filed: June 7, 2011
    Date of Patent: February 19, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Mukesh Kumar Madhra, Pankaj Kumar Singh, Chandra Has Khanduri
  • SORAFENIB ETHYLSULFONATE SALT, PROCESS FOR PREPARATION AND USE
    Publication number: 20130005777
    Abstract: The present invention provides sorafenib ethane sulphonate, process for its preparation, pharmaceutical composition comprising sorafenib ethane sulphonate and its use for the treatment of cancer. Formula (III).
    Type: Application
    Filed: November 12, 2010
    Publication date: January 3, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF SORAFENIB TOSYLATE
    Publication number: 20130005980
    Abstract: The present invention provides a process for the preparation of sorafenib tosylate, comprising contacting sorafenib free base with p-toluenesulphonic acid in water.
    Type: Application
    Filed: September 24, 2010
    Publication date: January 3, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • PHARMACEUTICAL COMPOSITION OF DONEPEZIL
    Publication number: 20120329831
    Abstract: The present invention relates to a pharmaceutical composition of donepezil or pharmaceutically acceptable salts thereof comprising ethyl cellulose and methacrylic acid copolymer in a ratio of more than 1.3. Further, it relates to process for preparation of said composition.
    Type: Application
    Filed: June 22, 2012
    Publication date: December 27, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Anuj Kumar FANDA, Kumaravel VIVEK, Romi Barat SINGH, Ajay Kumar SINGLA
  • PROCESSES FOR THE PREPARATION OF CINACALCET
    Publication number: 20120309842
    Abstract: The present invention provides processes and intermediates for preparing cinacalcet base and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 16, 2010
    Publication date: December 6, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sayeed Mukhtar, Dinesh Shashidharan Nair, Roshan Ramesh Medhane, Nitin Maheshwari, Hashim Nizar Poovanathil Nagoor Meeran, Neera Tewari, Mohan Prasad
  • PROCESSES FOR THE PREPARATION OF ERLOTINIB HYDROCHLORIDE FORM A AND ERLOTINIB HYDROCHLORIDE FORM B
    Publication number: 20120302749
    Abstract: The present invention relates to processes for the preparation of erlotinib hydrochloride Form A and erlotinib hydrochloride Form B. (I).
    Type: Application
    Filed: November 12, 2010
    Publication date: November 29, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Balaguru Murugesan, Anandam Vempali, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • MULTI-LAYERED, MULTIPLE UNIT PHARMACEUTICAL COMPOSITIONS
    Publication number: 20120288532
    Abstract: The invention relates to pharmaceutical compositions comprising multilayered multiple units and processes for the preparation thereof.
    Type: Application
    Filed: July 28, 2010
    Publication date: November 15, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Paras Jain, Umesh Vinayakrao Barabde, Kanwarpreet Singh Bakshi, Rajan Kumar Verma, Romi Barat Singh
  • DELAYED RELEASE PHARMACEUTICAL COMPOSITION OF MESALAMINE
    Publication number: 20120282333
    Abstract: The invention relates to a delayed release pharmaceutical composition of mesalamine comprising: a) granules comprising mesalamine or pharmaceutically acceptable salts thereof and a hydrophilic polymer; b) extragranular excipients; wherein the pharmaceutical composition is further coated with a single layer of polymer.
    Type: Application
    Filed: October 18, 2010
    Publication date: November 8, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Vasu Kumar Kakumanu, Anju Bansal, Shashikanth P. Isloor, Vinod Kumar Arora
  • CRYSTALLINE FORMS OF BOSENTAN SALTS AND PROCESSES FOR THEIR PREPARATION
    Publication number: 20120283440
    Abstract: The present invention relates to crystalline forms of bosentan salts and processes for their preparation.
    Type: Application
    Filed: November 12, 2010
    Publication date: November 8, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Rakesh Singh, Anu Mittal, Gopal Singh Bisht, Mahavir Singh Khanna, Rajesh Kumar Thaper, Mohan Prasad
  • PROCESS FOR THE PREPARATION OF CRYSTALLINE APREPITANT HAVING FORM I CONTENT
    Publication number: 20120277426
    Abstract: The present invention provides a process for preparation of crystalline aprepitant having not more than 15% by weight of Form I content which comprises, a) dissolving aprepitant in a suitable solvent to obtain a solution, b) cooling the solution to 10-15° C., c) optionally seeding the solution with aprepitant Form I crystals, d) adding an anti-solvent to the solution, and e) isolating crystalline aprepitant having not more than 15% by weight of Form I content.
    Type: Application
    Filed: June 2, 2010
    Publication date: November 1, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Deepak Mohanlal Jain, Maneck Khurana, Hiten Sharadchandra Mehta, Abhay Tatiya, Asok Nath, Sanjay Mahadeo Gade, Mohan Prasad, Subhash Dhar
  • PROCESSES FOR THE PREPARATION OF FORM I AND FORM II OF PALONOSETRON HYDROCHLORIDE
    Publication number: 20120267533
    Abstract: The present invention relates to processes for the preparation of Form I and Form II of palonosetron hydrochloride. The present invention further relates to a method of determining the polymorphic forms of palonosetron hydrochloride using Fourier-Transform Infra-red (FTIR) method.
    Type: Application
    Filed: June 30, 2010
    Publication date: October 25, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Gyanendra Pandey, Kaptan Singh, Surender Dhingra, Mohan Prasad, Tippasandra G. Chandrashekhar, Somenath Ganguly, Rita Santhakumar
  • PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM I OF L-MALIC ACID SALT OF SUNITINIB
    Publication number: 20120271056
    Abstract: The present invention relates to a process for the preparation of crystalline Form I of the L-malic acid salt of sunitinib.
    Type: Application
    Filed: November 12, 2010
    Publication date: October 25, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sudhir Singh Sanwal, Saridi Madhava Dileep Kumar, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • POLYMORPHS OF SORAFENIB ACID ADDITION SALTS
    Publication number: 20120264789
    Abstract: The present invention provides amorphous and crystalline forms of acid addition salts of sorafenib, pharmaceutical compositions comprising them and their use for the treatment of cancer. The present invention also provides processes for the preparation of acid addition salts of sorafenib.
    Type: Application
    Filed: September 24, 2010
    Publication date: October 18, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • TOPICAL RETNOID SOLUTIONS
    Publication number: 20120259014
    Abstract: The present invention relates to a topical solution comprising a retinoid or its pharmaceutically acceptable salts thereof and a process of preparing it.
    Type: Application
    Filed: May 20, 2010
    Publication date: October 11, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sanjay Kumar Motwani, Shashikanth P. Isloor, Vinod Arora